Segstro R, Seaman K L, Innes I R, Greenway C V
Can J Physiol Pharmacol. 1986 May;64(5):615-20. doi: 10.1139/y86-102.
Intravenous administration of hypotensive doses (30-200 micrograms/kg) of nifedipine to cats anesthetized with pentobarbital caused an increase in cardiac output accompanied by hepatic venoconstriction. The hepatic venoconstriction and the increase in cardiac output were abolished in animals in which the hepatic sympathetic nerves were cut, the adrenal glands were excluded, and the kidneys were removed. This contrasts with the indirect hepatic venoconstrictor action of isoproterenol which was shown previously not to be abolished by these procedures. Further experiments showed that the hepatic venoconstrictor effect of nifedipine was blocked by removal of the kidneys, but not by removal of the hepatic sympathetic nerves and adrenals. These results support the hypothesis that venoconstriction plays an important role when drugs produce increased cardiac output. In nephrectomized animals, nifedipine had no direct effects on hepatic blood volume and it did not alter the effects of infusions of norepinephrine on hepatic blood volume, which have previously been shown to be mediated through alpha 2-adrenoceptors. However, it did reduce the hepatic venous responses to hepatic sympathetic nerve stimulation by 30%.
对用戊巴比妥麻醉的猫静脉注射降压剂量(30 - 200微克/千克)的硝苯地平,会导致心输出量增加,并伴有肝静脉收缩。在切断肝交感神经、摘除肾上腺和切除肾脏的动物中,肝静脉收缩和心输出量增加被消除。这与异丙肾上腺素的间接肝静脉收缩作用形成对比,先前已表明这些操作不会消除异丙肾上腺素的这种作用。进一步的实验表明,硝苯地平的肝静脉收缩作用可通过切除肾脏而被阻断,但切除肝交感神经和肾上腺则不能。这些结果支持了这样的假说,即当药物使心输出量增加时,静脉收缩起重要作用。在肾切除的动物中,硝苯地平对肝血容量无直接影响,且不改变去甲肾上腺素输注对肝血容量的影响,先前已表明去甲肾上腺素对肝血容量的影响是通过α2 - 肾上腺素能受体介导的。然而,它确实使肝静脉对肝交感神经刺激的反应降低了30%。